PharmaCyte Biotech Inc (PMCB): BetaCell well ahead of PharmaCyte in T1...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	42
Posts	4850
Boards Moderated	0
Alias Born	08/06/2012

frosr6

Re: None

Friday, 05/27/2016 4:00:58 PM

Friday, May 27, 2016 4:00:58 PM

BetaCell well ahead of PharmaCyte in T1 Diabetes "cell therapy"! Looks like pmcb has failed again.
Beta-Cell NV is a privately-owned biotechnology company that develops innovative products for cell therapy in diabetes. Our goal is to provide diabetes patients and their doctors with cell-based transplants that restore endogenous insulin production.
Our proprietary lead product, BetaGraft®, is a defined porcine cell preparation which is encapsulated in injectable alginate beads. ?Beta-Cell’s product prototypes are based on patent-protected technology. BetaGraft® transplants have demonstrated metabolically adequate insulin production in relevant mouse models.
Furthermore, our patented alginate encapsulation technology has been applied in human volunteers.
Beta-Cell NV is a partner in a European consortium of clinical, research and biotech departments and institutions
http://www.beta-cell.com/home/

Fda trials
https://clinicaltrials.gov/ct2/results?term=Betacell&Search=Sear
ch

Disclosure: I am a involved in and support the SEC whistleblower program, I may be rewarded cash for information that leads to the successful enforcement by the SEC of a federal court or administrative action in $1m+.